Core Focus and Technology

Neuros Medical's central area of expertise is the treatment of chronic post-amputation pain, which includes both residual limb pain (also known as stump pain) and phantom limb pain. These conditions affect a significant portion of individuals who have undergone amputation and can profoundly diminish quality of life, mobility, and mental well-being.

The company's proprietary technology is built around a concept known as High-Frequency Nerve Block, also referred to as Electrical Nerve Block. Unlike traditional spinal cord stimulation or peripheral nerve stimulation systems that create a masking sensation (such as tingling or paresthesia) to cover pain signals, Neuros Medical's approach is designed to directly block the transmission of pain signals along the targeted peripheral nerve. This differentiated mechanism of action aims to interrupt the pain pathway before signals reach the brain, providing on-demand relief without relying on opioids or invasive surgical revisions.

Flagship Product: The Altius System

The centerpiece of Neuros Medical's product portfolio is the Altius System, an implantable neurostimulation device engineered specifically to treat chronic post-amputation pain in the lower limbs.

Key attributes of the Altius System include:

• On-Demand Therapy: The Altius System is designed to be patient-controlled, allowing individuals to activate therapy when they experience pain rather than delivering continuous stimulation. This gives patients a greater degree of autonomy and control over managing their symptoms.

• High-Frequency Electrical Nerve Block: The system delivers a high-frequency waveform intended to block pain signals directly at the peripheral nerve, distinguishing it from conventional low-frequency neurostimulation devices that create a paresthesia sensation.

• Implantable Design: The Altius System involves an implanted component that interfaces with the targeted nerve, along with an external controller that enables the patient to initiate treatment sessions.

• Non-Opioid Solution: A central value proposition of the Altius System is that it offers a drug-free alternative for chronic pain management, addressing the growing concern over opioid dependence and the limitations of pharmacological pain treatment.

The Altius System has been the subject of clinical investigation aimed at demonstrating its safety and effectiveness in reducing pain and reducing reliance on pain medications for amputees. The company pursued rigorous clinical trials to generate the evidence required for regulatory review by the U.S. Food and Drug Administration (FDA).

Clinical Evidence and Regulatory Progress

Neuros Medical has invested substantially in clinical research to validate its technology. The company conducted a pivotal randomized controlled trial to evaluate the Altius System in patients experiencing chronic post-amputation pain. This type of study design—considered the gold standard in medical research—was intended to provide robust evidence regarding both pain reduction and reduction in opioid consumption among treated patients.

The company's regulatory strategy has focused on securing FDA approval to bring the Altius System to the U.S. market as a treatment option for post-amputation pain. Achieving regulatory clearance and approval is a critical milestone for any implantable neurostimulation device, and Neuros Medical has worked to meet the stringent safety and efficacy standards required for such devices.

Target Patients and Clinical Need

The patient population served by Neuros Medical represents a group with a significant and often unmet medical need. Individuals who have undergone limb amputation—whether due to trauma, vascular disease, diabetes-related complications, cancer, or infection—frequently experience persistent and severe pain in the residual limb or phantom sensations in the missing limb.

Conventional treatments for these patients often include:

• Oral medications, including opioids, anticonvulsants, and antidepressants
• Physical therapy and rehabilitation
• Surgical revision of the residual limb
• Traditional neurostimulation approaches

Many of these approaches carry limitations, including incomplete pain relief, side effects, risk of dependency (in the case of opioids), and the need for repeated interventions. Neuros Medical's technology aims to fill this gap by offering a targeted, patient-controlled, non-pharmacological option specifically designed for this population.

Business and Industry Position

Neuros Medical operates as a venture-backed medical device company, having raised capital from investors to fund its research, clinical trials, and commercialization efforts. The company's focus on a specialized and underserved indication—post-amputation pain—differentiates it from larger neuromodulation companies that primarily target broader indications such as chronic back and leg pain through spinal cord stimulation.

By concentrating on the electrical nerve block mechanism and the specific needs of amputees, Neuros Medical has carved out a distinct niche within the competitive neuromodulation landscape. This specialization allows the company to develop deep clinical expertise and tailor its technology, clinical evidence, and commercial approach directly to the needs of amputee patients and the clinicians who treat them.

Significance and Impact

The work of Neuros Medical addresses several important themes in modern healthcare:

• Opioid Reduction: With the ongoing focus on reducing opioid use and dependence, Neuros Medical's non-opioid approach aligns with broader public health priorities and the desire to offer patients effective alternatives to pain medication.

• Quality of Life: Chronic post-amputation pain can severely limit a person's ability to use prosthetics, remain physically active, and maintain independence. Effective pain management can meaningfully improve mobility, function, and psychological well-being.

• Innovation in Neuromodulation: The company's differentiated nerve block technology represents an advancement in how electrical stimulation is used to manage pain, moving beyond the traditional paresthesia-based paradigm toward direct signal blocking.

Summary

Neuros Medical is a MedTech company focused on the treatment of chronic post-amputation pain through its proprietary high-frequency electrical nerve block technology. Its flagship Altius System is an implantable, patient-controlled neurostimulation device designed to block pain signals at the peripheral nerve, offering amputees a non-opioid alternative for managing residual limb and phantom limb pain. Through significant investment in clinical research and its pursuit of FDA regulatory approval, Neuros Medical seeks to address a longstanding unmet need among amputees and to advance the field of neuromodulation with a distinctive, targeted therapeutic approach.